We are live on ! Find out more
SIC

Samalin Investment Counsel Portfolio holdings

AUM $320M
1-Year Est. Return 20.87%
This Fund
S&P 500
This Quarter Est. Return
+11.39%
1 Year Est. Return
+20.87%
3 Year Est. Return
+62.81%
5 Year Est. Return
+65.92%
10 Year Est. Return
AUM
$320M
AUM Growth
+$38M
Cap. Flow
+$12.4M
Cap. Flow %
3.87%
Top 10 Hldgs %
19.03%
Holding
352
New
33
Increased
150
Reduced
150
Closed
16

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$1.77M
2
GLD icon
SPDR Gold Trust
GLD
+$1.35M
3
FLEX icon
Flex
FLEX
+$876K
4
CCJ icon
Cameco
CCJ
+$603K
5
PG icon
Procter & Gamble
PG
+$553K

Sector Composition

Rank Sector Weight
1 Financials 9.66%
2 Technology 9.51%
3 Real Estate 5.62%
4 Healthcare 4.36%
5 Energy 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
76
Procter & Gamble
PG
$339B
$1.05M 0.33%
7,167
-3,799
-35% -$553K
ET icon
77
Energy Transfer Partners
ET
$69.5B
$1.03M 0.32%
53,841
+757
+1% +$14.7K
HD icon
78
Home Depot
HD
$337B
$1.03M 0.32%
2,907
-75
-3% -$24.4K
ERO icon
79
Ero Copper
ERO
$2.63B
$1.01M 0.32%
37,803
+589
+2% +$16.7K
MO icon
80
Altria Group
MO
$125B
$994K 0.31%
13,810
-232
-2% -$16.2K
GS icon
81
Goldman Sachs
GS
$289B
$978K 0.31%
967
+26
+3% +$25.3K
LLY icon
82
Eli Lilly
LLY
$1.08T
$976K 0.31%
814
-26
-3% -$26.6K
LXP icon
83
LXP Industrial Trust
LXP
$3.52B
$956K 0.3%
17,748
+343
+2% +$17.7K
LRCX icon
84
Lam Research
LRCX
$319B
$946K 0.3%
2,182
+28
+1% +$8.5K
V icon
85
Visa
V
$703B
$943K 0.29%
2,748
-25
-0.9% -$8.03K
WLKP icon
86
Westlake Chemical Partners
WLKP
$773M
$940K 0.29%
42,248
+358
+0.9% +$8.16K
CHCT
87
Community Healthcare Trust
CHCT
$536M
$940K 0.29%
51,422
+807
+2% +$14K
CVX icon
88
Chevron
CVX
$383B
$921K 0.29%
5,555
+179
+3% +$33.3K
GSL icon
89
Global Ship Lease
GSL
$1.57B
$917K 0.29%
24,394
+730
+3% +$28.5K
GOOG icon
90
Alphabet (Google) Class C
GOOG
$4.1T
$905K 0.28%
2,560
-50
-2% -$17.9K
RFI
91
Cohen & Steers Total Return Realty Fund
RFI
$312M
$873K 0.27%
77,105
+1,514
+2% +$17.2K
O icon
92
Realty Income
O
$61.1B
$850K 0.27%
13,725
-3,118
-19% -$194K
NVO
93
Novo Nordisk
NVO
$228B
$830K 0.26%
17,321
+7,315
+73% +$314K
PCF
94
High Income Securities Fund
PCF
$99M
$822K 0.26%
150,363
+24,685
+20% +$138K
C icon
95
Citigroup
C
$214B
$809K 0.25%
5,779
-378
-6% -$49.2K
AWP
96
abrdn Global Premier Properties Fund
AWP
$374M
$787K 0.25%
66,499
-38,546
-37% -$453K
CHY
97
Calamos Convertible and High Income Fund
CHY
$976M
$786K 0.25%
57,743
+1,115
+2% +$14.1K
FLEX icon
98
Flex
FLEX
$37.5B
$765K 0.24%
4,722
-7,227
-60% -$876K
IVV icon
99
iShares Core S&P 500 ETF
IVV
$859B
$762K 0.24%
1,018
-103
-9% -$75K
ABBV icon
100
AbbVie
ABBV
$466B
$761K 0.24%
3,023
-431
-12% -$92.7K

Similar funds

Samalin Investment Counsel's Q2 2026 Portfolio in Review

As of Q2 2026, Samalin Investment Counsel held 352 positions worth $320M, up 13% from $282M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Samalin Investment Counsel deployed $12.4M of net new capital in Q2 2026, opening 33 new positions and adding to 150 existing holdings. Its largest new stake was CVS Health: 12,860 shares worth $1.33M.

By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 10% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Micron Technology, an estimated $1.77M trimmed.

  • Samalin Investment Counsel's largest Q2 2026 buy was CVS Health: 12,860 shares worth $1.33M.
  • Samalin Investment Counsel added most to Schwab US Dividend Equity ETF in Q2 2026, an estimated $1.52M increase.
  • Samalin Investment Counsel's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.77M.
  • Samalin Investment Counsel fully exited Cameco in Q2 2026, selling an estimated $603K.
  • Samalin Investment Counsel's ten largest holdings make up 19% of its $320M portfolio in Q2 2026.
  • Samalin Investment Counsel opened 33 new positions and closed 16 in Q2 2026.
  • Samalin Investment Counsel's portfolio value rose 13% quarter-over-quarter to $320M.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.